Literature DB >> 13996265

[Fetal indications for cesarean section].

P VARA.   

Abstract

Keywords:  BLOOD GROUP INCOMPATIBILITY; CESAREAN SECTION; FETAL DISEASES; PREGNANCY, PROLONGED

Mesh:

Year:  1963        PMID: 13996265     DOI: 10.1007/bf00674190

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


× No keyword cloud information.
  11 in total

1.  [Results of extended indication for cesarean section as reflected in Hamburg obstetric statistics].

Authors:  H MITTELSTRASS; P WINCKELMANN
Journal:  Geburtshilfe Frauenheilkd       Date:  1955-04       Impact factor: 2.915

2.  [Obstetrical causes of perinatal fetal mortality].

Authors:  H NOACK
Journal:  Ann Chir Gynaecol Fenn Suppl       Date:  1958

3.  [Perinital infant mortality at the Universitäts-Frauenklinik Basel, 1906-1955].

Authors:  J BERGER
Journal:  Arch Gynakol       Date:  1957

4.  Perinatal infant mortality associated with a conservative policy regarding cesarean section: analysis of 7,871 deliveries at the North Carolina Baptist Hospital.

Authors:  F R LOCK; J MAY
Journal:  South Med J       Date:  1957-10       Impact factor: 0.954

5.  [Cesarean section in current obstetrics].

Authors:  P VARA
Journal:  Gynaecologia       Date:  1958-07

6.  Cesarean section in New York City; incidence and mortality during 1954-55.

Authors:  C L ERHARDT; E M GOLD
Journal:  Obstet Gynecol       Date:  1958-03       Impact factor: 7.661

7.  Recent trends in cesarean section; a review of 2066 consecutive operations.

Authors:  E G WATERS
Journal:  Obstet Gynecol       Date:  1958-06       Impact factor: 7.661

8.  Pregnancy and diabetes mellitus; a clinical study.

Authors:  L HAGBARD
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1956

9.  [The present state of abdominal cesarean section].

Authors:  G DODERLEIN
Journal:  Munch Med Wochenschr       Date:  1953-01-02

10.  The place of caesarean section in obstetrics today.

Authors:  P VARA
Journal:  Acta Obstet Gynecol Scand       Date:  1952       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.